Skip to content
Search

Latest Stories

RPS president says “still a very long way to go to achieve gender equity” in pharmacy

There is still a long way to go to achieve gender equality in pharmacy in both academia and profession, Royal Pharmaceutical Society (RPS) president Claire Anderson said while addressing a webinar on ‘Driving equality for women in pharmacy today (November 19).

Sharing her personal experience, Anderson, who earlier worked as an academic, said: “I was the first ever female professor in the School of Pharmacy at Nottingham when I was appointed as professor in 2003, and at that point, only 11 per cent of professors in my university were female.”


She acknowledged that the situation has changed since then, but “there's still a very long way to go to achieve gender equity in most of academia, and in pharmacy, in particular.”

She added that the profession has ensured safe spaces for women but noted that is not enough, as gender equity is vital to achieve healthier and safer societies.

“And although our work on equality, diversity and inclusion is progressing very well, I think we're still not there. It's a journey and there's much to be achieved.”

Quoting a media investigation RPS CEO Paul Bennett said that only two per cent of pharmacy business owners are women, while 13 per cent are men.

He said: “Women in senior pharmacy leadership positions across our profession have much lower numbers than they would be if they reflect the numbers of females in the profession. And the bias remains in systems and structures, that mean the gender parity is not achieved.”

He added that gender disparity issue has been highlighted for over several years now, therefore, “we hold all of us in any position of influence to champion inclusive leadership and to support women from diverse backgrounds across all levels of policy to become leaders.”

It is the moral obligation of leaders to “use their influence to champion the rights of their female colleagues to grow in their careers and advanced in positions of leadership.”

Approving the view that gender equality in the pharmacy sector is still a far-fetched dream, head of Equality & Inclusion at NHS England, Harprit Hockley said that 78 per cent of the NHS staff comprises women but “that's not reflected in our senior roles or nor is it reflected in the decision making process.”

She explained that NHS has tried to debias individuals through training but noted that “one hour to three hours of training is not going to dismantle decades of that negative narrative.”

Therefore, the thrust needs to be on bringing in systematic changes and breaking down the barriers that obstruct achieving gender equity.

More For You

Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less
Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less